Schmitt Industries (SMIT) Competitors $0.02 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends SMIT vs. SPEC, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, THMO, TT, KEYS, and FTVShould you be buying Schmitt Industries stock or one of its competitors? The main competitors of Schmitt Industries include Spectaire (SPEC), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), ThermoGenesis (THMO), Trane Technologies (TT), Keysight Technologies (KEYS), and Fortive (FTV). These companies are all part of the "measuring and control equipment" industry. Schmitt Industries vs. Spectaire HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition ThermoGenesis Trane Technologies Keysight Technologies Fortive Schmitt Industries (NASDAQ:SMIT) and Spectaire (NASDAQ:SPEC) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and earnings. Which has stronger valuation and earnings, SMIT or SPEC? Spectaire has lower revenue, but higher earnings than Schmitt Industries. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSchmitt Industries$9.89M0.01-$3.28MN/AN/ASpectaireN/AN/A$8.95MN/AN/A Is SMIT or SPEC more profitable? Schmitt Industries' return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets Schmitt IndustriesN/A N/A N/A Spectaire N/A -81.22%304.57% Does the MarketBeat Community prefer SMIT or SPEC? Schmitt Industries received 94 more outperform votes than Spectaire when rated by MarketBeat users. Likewise, 55.29% of users gave Schmitt Industries an outperform vote while only 0.00% of users gave Spectaire an outperform vote. CompanyUnderperformOutperformSchmitt IndustriesOutperform Votes9455.29% Underperform Votes7644.71% SpectaireOutperform VotesNo VotesUnderperform Votes1100.00% Do institutionals and insiders have more ownership in SMIT or SPEC? 26.5% of Spectaire shares are held by institutional investors. 17.1% of Schmitt Industries shares are held by company insiders. Comparatively, 25.4% of Spectaire shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, SMIT or SPEC? Schmitt Industries has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. Comparatively, Spectaire has a beta of -0.56, meaning that its share price is 156% less volatile than the S&P 500. Does the media prefer SMIT or SPEC? In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled Spectaire'saverage media sentiment score. Company Overall Sentiment Schmitt Industries Neutral Spectaire Neutral SummarySchmitt Industries beats Spectaire on 5 of the 9 factors compared between the two stocks. Get Schmitt Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for SMIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMIT vs. The Competition Export to ExcelMetricSchmitt IndustriesProcess control instruments IndustryIndustrial SectorNASDAQ ExchangeMarket Cap$69,000.00$19.75B$9.17B$9.14BDividend YieldN/A0.74%2.10%3.85%P/E RatioN/A28.2616.9119.18Price / Sales0.015.674.3370.76Price / CashN/A18.6922.0934.83Price / BookN/A4.194.414.62Net Income-$3.28M$492.30M$424.79M$246.06M7 Day PerformanceN/A-4.03%-2.87%-2.63%1 Month PerformanceN/A-6.48%-5.50%-2.15%1 Year PerformanceN/A1.41%29.45%12.88% Schmitt Industries Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMITSchmitt IndustriesN/A$0.02flatN/AN/A$69,000.00$9.89M0.00160SPECSpectaireN/A$0.00flatN/AN/A$2,000.00N/A0.008HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09+10.4%N/A-18.3%$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.01+8.1%N/A+66.7%$0.00$25.56M0.001Negative NewsGap DownQSIAWQuantum-SiN/A$0.73-4.6%N/A+220.3%$0.00$2.27M0.00150Negative NewsSMAPWSportsMap Tech AcquisitionN/A$0.07+23.3%N/AN/A$0.00N/A0.00N/AGap UpTHMOThermoGenesisN/AN/AN/AN/A$0.00$9.44M0.0040News CoverageTTTrane Technologies4.4066 of 5 stars$363.58+0.6%$415.25+14.2%+28.3%$81.81B$19.84B32.3240,000Analyst RevisionPositive NewsKEYSKeysight Technologies3.9438 of 5 stars$183.40+2.3%$180.80-1.4%+21.7%$31.71B$4.98B52.4015,500Upcoming EarningsAnalyst UpgradePositive NewsFTVFortive4.4848 of 5 stars$80.59-1.3%$87.64+8.7%-5.2%$27.96B$6.07B32.1118,000Positive News Related Companies and Tools Related Companies Spectaire Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors ThermoGenesis Competitors Trane Technologies Competitors Keysight Technologies Competitors Fortive Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMIT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schmitt Industries, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schmitt Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
